Loading insider details...
Beta
Latest Form 4 (Jul 28, 2026): Grant/Award of 2,538 HAE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | HAEMONETICS CORP (HAE) | Grant/Award | 2,538 | n/a |
| Nov 12, 2025 | HAEMONETICS CORP (HAE) | Purchase | 1,400 | $98.8K |
| Jul 25, 2025 | HAEMONETICS CORP (HAE) | Grant/Award | 2,693 | n/a |
| Jul 26, 2024 | HAEMONETICS CORP (HAE) | Grant/Award | 2,207 | n/a |
| Aug 8, 2023 | HAEMONETICS CORP (HAE) | Grant/Award | 2,226 | n/a |
| May 16, 2023 | AXON ENTERPRISE, INC. (AXON) | Grant/Award | 993 | n/a |
| Mar 8, 2023 | AXON ENTERPRISE, INC. (AXON) | Sale | 92 | $20.3K |
| Aug 16, 2022 | HAEMONETICS CORP (HAE) | Sale | 8,016 | $590.9K |
| Aug 8, 2022 | HAEMONETICS CORP (HAE) | Grant/Award | 2,730 | n/a |
| Jun 9, 2022 | AXON ENTERPRISE, INC. (AXON) | Sale | 3,159 | $324.8K |